Keywords: merck, kgaa, returns, rights, biomira, theratope, germany

Merck KGaA returns rights to Biomira's Theratope

Article | 14 June 2004

Germany's Merck KGaA and Canada's Biomira have agreed that development and commercialization rights to the therapeutic cancer vaccine Theratope will ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Merck

Merck KGaA

Go to company listing